会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 再颁专利
    • Method for making surfactant-templated thin films
    • 制备表面活性剂模板薄膜的方法
    • USRE41612E1
    • 2010-08-31
    • US10670187
    • 2003-09-23
    • C. Jeffrey BrinkerYunfeng LuHong You Fan
    • C. Jeffrey BrinkerYunfeng LuHong You Fan
    • B05D3/02B05D1/02B05D1/18B05D3/10B05D3/12
    • B82Y30/00
    • An evaporation-induced self-assembly method to prepare a porous, surfactant-templated, thin film by mixing a silica sol, a solvent, a surfactant, and an interstitial compound, evaporating a portion of the solvent to form a liquid, crystalline thin film mesophase material, and then removal of the surfactant template. Coating onto a substrate produces a thin film with the interstitial compound either covalently bonded to the internal surfaces of the ordered or disordered mesostructure framework or physically entrapped within the ordered or disordered mesostructured framework. Particles can be formed by aerosol processing or spray drying rather than coating onto a substrate. The selection of the interstitial compound provides a means for developing thin films for applications including membranes, sensors, low dielectric constant films, photonic materials and optical hosts.
    • 通过混合硅溶胶,溶剂,表面活性剂和间隙化合物制备多孔表面活性剂模板化薄膜的蒸发诱导自组装方法,蒸发溶剂的一部分以形成液体,晶体薄膜 中间相材料,然后除去表面活性剂模板。 涂覆在基材上产生薄膜,其中间隙化合物共价键合到有序或无序的介观结构框架的内表面或物理地截留在有序或无序的介观结构框架内。 颗粒可以通过气溶胶处理或喷雾干燥形成,而不是涂覆在基材上。 间隙化合物的选择提供了一种用于开发用于包括膜,传感器,低介电常数膜,光子材料和光学主体的薄膜的薄膜的方法。
    • 3. 发明授权
    • Method for making surfactant-templated, high-porosity thin films
    • 制备表面活性剂模板,高孔隙率薄膜的方法
    • US06270846B1
    • 2001-08-07
    • US09517689
    • 2000-03-02
    • C. Jeffrey BrinkerYunfeng LuHongyou Fan
    • C. Jeffrey BrinkerYunfeng LuHongyou Fan
    • B05B500
    • B01F17/0028B01F17/0021B01F17/0042B01F17/0057B01F17/0064C03C17/007C03C17/009C03C2217/425Y10T428/21Y10T428/24331
    • An evaporation-induced self-assembly method to prepare a surfactant-templated thin film by mixing a silica sol, a surfactant, and a hydrophobic polymer and then evaporating a portion of the solvent during coating onto a substrate and then heating to form a liquid-phase, thin film material with a porosity greater than approximately 50 percent. The high porosity thin films can have dielectric constants less than 2 to be suitable for applications requiring low-dielectric constants. An interstitial compound can be added to the mixture, with the interstitial compound either covalently bonded to the pores or physically entrapped within the porous structure. The selection of the interstitial compound provides a means for developing thin films for applications including membranes, sensors, low dielectric constant films, photonic materials and optical hosts.
    • 蒸发诱导的自组装方法,通过混合二氧化硅溶胶,表面活性剂和疏水聚合物制备表面活性剂模板化薄膜,然后在涂布过程中将一部分溶剂蒸发到基底上,然后加热形成液体 - 孔隙率大于约50%的薄膜材料。 高孔隙率薄膜可以具有小于2的介电常数,以适用于需要低介电常数的应用。 间隙化合物可以加入到混合物中,间隙化合物共价键合到孔或物理地截留在多孔结构内。 间隙化合物的选择提供了一种用于开发用于包括膜,传感器,低介电常数膜,光子材料和光学主体的薄膜的薄膜的方法。
    • 4. 发明授权
    • Self-assembly of nanocomposite materials
    • 纳米复合材料的自组装
    • US06264741B1
    • 2001-07-24
    • US09449036
    • 1999-11-24
    • C. Jeffrey BrinkerAlan SellingerYunfeng Lu
    • C. Jeffrey BrinkerAlan SellingerYunfeng Lu
    • C30B1110
    • B82Y30/00C09K19/00
    • A method of making a nanocomposite self-assembly is provided where at least one hydrophilic compound, at least one hydrophobic compound, and at least one amphiphilic surfactant are mixed in an aqueous solvent with the solvent subsequently evaporated to form a self-assembled liquid crystalline mesophase material. Upon polymerization of the hydrophilic and hydrophobic compounds, a robust nanocomposite self-assembled material is formed. Importantly, in the reaction mixture, the amphiphilic surfactant has an initial concentration below the critical micelle concentration to allow formation of the liquid-phase micellar mesophase material. A variety of nanocomposite structures can be formed, depending upon the solvent evaporazation process, including layered mesophases, tubular mesophases, and a hierarchical composite coating composed of an isotropic worm-like micellar overlayer bonded to an oriented, nanolaminated underlayer.
    • 提供制备纳米复合自组装的方法,其中至少一种亲水性化合物,至少一种疏水性化合物和至少一种两亲表面活性剂在水性溶剂中与溶剂混合,随后蒸发形成自组装液晶中间相 材料。 在聚合亲水和疏水化合物时,形成了坚固的纳米复合材料自组装材料。 重要的是,在反应混合物中,两亲表面活性剂的初始浓度低于临界胶束浓度以允许形成液相胶束中间相材料。 可以形成各种纳米复合结构,这取决于溶剂蒸发过程,包括层状中间相,管状中间相,和由定向的纳米层压底层粘合的各向同性的蠕虫状胶束覆盖层组成的分级复合涂层。
    • 5. 发明授权
    • Method for making surfactant-templated thin films
    • 制备表面活性剂模板薄膜的方法
    • US06387453B1
    • 2002-05-14
    • US09517873
    • 2000-03-02
    • C. Jeffrey BrinkerYunfeng LuHongyou Fan
    • C. Jeffrey BrinkerYunfeng LuHongyou Fan
    • B05D302
    • B82Y30/00
    • An evaporation-induced self-assembly method to prepare a porous, surfactant-templated, thin film by mixing a silica sol, a solvent, a surfactant, and an interstitial compound, evaporating a portion of the solvent to form a liquid, crystalline thin film mesophase material, and then removal of the surfactant template. Coating onto a substrate produces a thin film with the interstitial compound either covalently bonded to the internal surfaces of the ordered or disordered mesostructure framework or physically entrapped within the ordered or disordered mesostructured framework. Particles can be formed by aerosol processing or spray drying rather than coating onto a substrate. The selection of the interstitial compound provides a means for developing thin films for applications including membranes, sensors, low dielectric constant films, photonic materials and optical hosts.
    • 通过混合硅溶胶,溶剂,表面活性剂和间隙化合物制备多孔表面活性剂模板化薄膜的蒸发诱导自组装方法,蒸发溶剂的一部分以形成液体,晶体薄膜 中间相材料,然后除去表面活性剂模板。 涂覆在基材上产生薄膜,其中间隙化合物共价键合到有序或无序的介观结构框架的内表面或物理地截留在有序或无序的介观结构框架内。 颗粒可以通过气溶胶处理或喷雾干燥形成,而不是涂覆在基材上。 间隙化合物的选择提供了一种用于开发用于包括膜,传感器,低介电常数膜,光子材料和光学主体的薄膜的薄膜的方法。
    • 7. 发明申请
    • POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME
    • 用于定向输送的多孔纳米脂质载体(PROTOCELLS)及其使用方法
    • US20140079774A1
    • 2014-03-20
    • US14113371
    • 2012-04-27
    • C. Jeffrey BrinkerEric C. CarnesCarleen Erin Ashley
    • C. Jeffrey BrinkerEric C. CarnesCarleen Erin Ashley
    • A61K9/127A61K45/06A61K31/704A61K31/711
    • A61K9/1271A61K31/704A61K31/711A61K33/24A61K38/00A61K39/05A61K45/06A61K47/62A61K47/6901A61K48/0016C07K14/47C12N15/1135C12N15/88C12N2310/14C12N2320/32C12N2810/40
    • The present invention is directed to protocells for specific targeting of hepatocellular and other cancer cells which comprise a nanoporous silica core with a supported lipid bilayer; at least one agent which facilitates cancer cell death (such as a traditional small molecule, a macromolecular cargo (e.g. siRNA or a protein toxin such as ricin toxin A-chain or diphtheria toxin A-chain) and/or a histone-packaged plasmid DNA disposed within the nanoporous silica core (preferably supercoiled in order to more efficiently package the DNA into protocells) which is optionally modified with a nuclear localization sequence to assist in localizing protocells within the nucleus of the cancer cell and the ability to express peptides involved in therapy (apoptosis/cell death) of the cancer cell or as a reporter, a targeting peptide which targets cancer cells in tissue to be treated such that binding of the protocell to the targeted cells is specific and enhanced and a fusogenic peptide that promotes endosomal escape of protocells and encapsulated DNA. Protocells according to the present invention may be used to treat cancer, especially including hepatocellular (liver) cancer using novel binding peptides (c-MET peptides) which selectively bind to hepatocellular tissue or to function in diagnosis of cancer, including cancer treatment and drug discovery.
    • 本发明涉及用于特异性靶向肝细胞和其它癌细胞的原细胞,其包含具有支持的脂质双层的纳米多孔二氧化硅核心; 促进癌细胞死亡的至少一种试剂(例如传统的小分子,大分子货物(例如siRNA或蛋白质毒素如蓖麻毒素A链或白喉毒素A链)和/或组蛋白包装的质粒DNA 设置在纳米多孔硅芯内(优选超螺旋以更有效地将DNA包装到原细胞中),其任选地用核定位序列修饰以帮助定位癌细胞核内的原细胞,以及表达参与治疗的肽的能力 (凋亡/细胞死亡)或作为报告物,靶向肽靶向待治疗的组织中的癌细胞,使得原细胞与靶细胞的结合是特异性和增强的,并且促进内体逃逸的融合肽 原细胞和包封的DNA。根据本发明的原细胞可用于治疗癌症,特别是包括肝细胞(肝)癌症 选择性结合肝细胞组织或在癌症诊断中起作用的新型结合肽(c-MET肽),包括癌症治疗和药物发现。